Oxford Nanopore Technologies PLC (LSE:ONT), the LSE-listed DNA sequencing company, has drawn positive reviews from RBC Capital Markets and Citi following its annual London Calling customer conference last week, with both brokers reiterating buy-equivalent ratings on the stock. RBC Capital Markets carries an outperform rating and 225p target price, while Citi rates the shares buy with a high-risk designation, noting that Oxford Nanopore trades on just 2.3 times estimated 2027 enterprise value to sales, which it considers compelling given the company's growth profile.
Onterris Inc (ONT) Q1 2026 Earnings Call Transcript
Montrose Environmental (ONT) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.07 per share a year ago.